Share Twitter LinkedIn Facebook Email James J. Hsieh MD PhD Professor, Molecular Oncology, Siteman Cancer Center, Washington University in St. Louis discusses RCC Profiling from the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read
Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024: AVEO Kidney 4 Mins Read
Impact of Latino Ethnicity on Gut Microbiome in mRCC: ASCO 2024 Study – Regina Barragan-Carillo, Phd – City of Hope ASCO Annual Meeting 2 Mins Read